arrow
L

Lars H. Lund

karolinska institutet
H指数:104
被引数:6.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Myeloperoxidase inhibition with mitiperstat in heart failure with preserved or mildly reduced ejection fraction: a randomized phase 2b trial

米替哌stat抑制髓过氧化物酶在射血分数保留或轻度降低的心力衰竭中的应用:一项随机2b期试验

2026-09-090
PRE
Type 2 diabetes and chronic kidney disease combinations in heart failure across the ejection fraction spectrum: clinical associations, medication use, and cause-specific outcomes: a contemporary, real-world analysis of the Swedish Heart Failure Registry

心力衰竭中射血分数谱范围内的2型糖尿病与慢性肾脏疾病合并情况:临床关联、药物使用和特定原因结局:一项基于瑞典心力衰竭登记系统的当代真实世界分析

2026-09-020
PRE
“Real-world prognostic performance of different severe and advanced heart failure definitions: data from the Swedish Heart Failure Registry”

“不同严重和晚期心力衰竭定义的现实世界预后表现:瑞典心力衰竭登记研究的数据”

2026-03-180
OAAI
Pharmacological treatment patterns and outcomes according to the coexistence of heart failure and Type 2 diabetes: data from the Swedish Heart Failure Registry and National Diabetes Registry

根据心力衰竭和2型糖尿病共存情况的心力衰竭药物治疗方法及结局:来自瑞典心力衰竭登记册和全国糖尿病登记册的数据

2026-01-011
PRE
Timing of Cardiac Resynchronization Therapy Following Stable Medical Therapy in Patients With Heart Failure

心力衰竭患者稳定药物治疗后的心脏再同步治疗时机

2025-06-200
OAAI